Brian A. Vesely

1.4k total citations
52 papers, 968 citations indexed

About

Brian A. Vesely is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology and Infectious Diseases. According to data from OpenAlex, Brian A. Vesely has authored 52 papers receiving a total of 968 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Public Health, Environmental and Occupational Health, 12 papers in Molecular Biology and 10 papers in Infectious Diseases. Recurrent topics in Brian A. Vesely's work include Malaria Research and Control (13 papers), Research on Leishmaniasis Studies (11 papers) and Mosquito-borne diseases and control (5 papers). Brian A. Vesely is often cited by papers focused on Malaria Research and Control (13 papers), Research on Leishmaniasis Studies (11 papers) and Mosquito-borne diseases and control (5 papers). Brian A. Vesely collaborates with scholars based in United States, Thailand and United Kingdom. Brian A. Vesely's co-authors include William R. Gower, David L. Vesely, Abdel A. Alli, Dennis E. Kyle, Juan Sanchez‐Ramos, Shijie Song, Diana Caridha, Richard J. Sciotti, Gina Della Togna and Quentin McAfee and has published in prestigious journals such as Nature Communications, PLoS ONE and Scientific Reports.

In The Last Decade

Brian A. Vesely

48 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian A. Vesely United States 20 361 299 248 180 155 52 968
Carmen Raventós-Suárez United States 16 408 1.1× 424 1.4× 212 0.9× 134 0.7× 111 0.7× 24 1.5k
Girish Rachakonda United States 20 720 2.0× 177 0.6× 114 0.5× 299 1.7× 220 1.4× 36 1.3k
Shusaku Mizukami Japan 18 762 2.1× 156 0.5× 264 1.1× 116 0.6× 25 0.2× 45 1.4k
M Ghione Italy 16 253 0.7× 99 0.3× 130 0.5× 87 0.5× 71 0.5× 56 721
Sameena Khan India 20 619 1.7× 153 0.5× 82 0.3× 122 0.7× 29 0.2× 43 1.0k
K. Vosbeck Switzerland 18 608 1.7× 66 0.2× 143 0.6× 120 0.7× 264 1.7× 36 1.3k
Annette L. Bodley United States 12 539 1.5× 239 0.8× 172 0.7× 91 0.5× 205 1.3× 13 833
Hairong Xiong China 20 437 1.2× 78 0.3× 74 0.3× 237 1.3× 28 0.2× 53 1.2k
Pia Rauch Germany 16 534 1.5× 94 0.3× 183 0.7× 107 0.6× 59 0.4× 34 1.3k
Olga A. Smirnova Russia 19 514 1.4× 74 0.2× 43 0.2× 335 1.9× 88 0.6× 64 1.2k

Countries citing papers authored by Brian A. Vesely

Since Specialization
Citations

This map shows the geographic impact of Brian A. Vesely's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian A. Vesely with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian A. Vesely more than expected).

Fields of papers citing papers by Brian A. Vesely

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian A. Vesely. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian A. Vesely. The network helps show where Brian A. Vesely may publish in the future.

Co-authorship network of co-authors of Brian A. Vesely

This figure shows the co-authorship network connecting the top 25 collaborators of Brian A. Vesely. A scholar is included among the top collaborators of Brian A. Vesely based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian A. Vesely. Brian A. Vesely is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Limsalakpetch, Amporn, Utaiwan Kum-Arb, Kosol Yongvanitchit, et al.. (2025). mRNA-LNP vaccine encoding the Plasmodium vivax circumsporozoite protein is highly immunogenic and confers protection in mice. Molecular Therapy — Nucleic Acids. 36(3). 102645–102645.
2.
Vanachayangkul, Pattaraporn, Rawiwan Im‐Erbsin, Anchalee Tungtaeng, et al.. (2024). Safety, pharmacokinetics, and potential neurological interactions of ivermectin, tafenoquine, and chloroquine in Rhesus macaques. Antimicrobial Agents and Chemotherapy. 68(6). e0018124–e0018124. 1 indexed citations
3.
4.
5.
Guo, Bing, Víctor Borda, Michele Spring, et al.. (2024). Strong positive selection biases identity-by-descent-based inferences of recent demography and population structure in Plasmodium falciparum. Nature Communications. 15(1). 2499–2499. 13 indexed citations
6.
Vesely, Brian A., et al.. (2022). A single point mutation in the Plasmodium falciparum 3′–5′ exonuclease does not alter piperaquine susceptibility. Malaria Journal. 21(1). 130–130. 2 indexed citations
7.
Sriwichai, Sabaithip, Krisada Jongsakul, Mark M. Fukuda, et al.. (2021). Molecular Detection of Mutations in the Propeller Domain of Kelch 13 and pfmdr1 Copy Number Variation in Plasmodium falciparum Isolates from Thailand Collected from 2002 to 2007. American Journal of Tropical Medicine and Hygiene. 105(4). 1093–1096. 3 indexed citations
8.
Corey, Brendan W., et al.. (2021). First Report: Colistin Resistance Gene mcr-3.1 in Salmonella enterica Serotype Choleraesuis Isolated from Human Blood Sample from Thailand. Microbial Drug Resistance. 28(1). 102–105. 4 indexed citations
9.
Lertsethtakarn, Paphavee, et al.. (2021). Characterization of Arcobacter spp. Isolated from human diarrheal, non-diarrheal and food samples in Thailand. PLoS ONE. 16(2). e0246598–e0246598. 9 indexed citations
10.
11.
Vesely, Brian A., Paphavee Lertsethtakarn, Panita Gosi, et al.. (2020). Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization. Malaria Journal. 19(1). 269–269. 22 indexed citations
12.
Caridha, Diana, Mark Hickman, Lisa Xie, et al.. (2019). Updating the modified Thompson test by using whole-body bioluminescence imaging to replace traditional efficacy testing in experimental models of murine malaria. Malaria Journal. 18(1). 38–38. 6 indexed citations
13.
Wilson, Nerida G., et al.. (2014). Shagenes A and B, New Tricyclic Sesquiterpenes Produced by an Undescribed Antarctic Octocoral. Organic Letters. 16(10). 2630–2633. 29 indexed citations
14.
Sanchez, Laura M., Dioxelis Lopéz, Brian A. Vesely, et al.. (2010). Almiramides A−C: Discovery and Development of a New Class of Leishmaniasis Lead Compounds. Journal of Medicinal Chemistry. 53(10). 4187–4197. 82 indexed citations
15.
Vesely, Brian A., et al.. (2007). Four Cardiac Hormones Cause Cell Death of Melanoma Cells and Inhibit Their DNA Synthesis. The American Journal of the Medical Sciences. 334(5). 342–349. 14 indexed citations
16.
Vesely, Brian A., et al.. (2006). Four cardiac hormones eliminate up to 82% of human medullary thyroid carcinoma cells within 24 hours. Endocrine. 30(3). 325–332. 17 indexed citations
17.
18.
Vesely, Brian A., Abdel A. Alli, Shijie Song, et al.. (2005). Four peptide hormones’ specific decrease (up to 97%) of human prostate carcinoma cells. European Journal of Clinical Investigation. 35(11). 700–710. 42 indexed citations
19.
Vesely, Brian A., Shijie Song, Juan Sanchez‐Ramos, et al.. (2005). Five cardiac hormones decrease the number of human small‐cell lung cancer cells. European Journal of Clinical Investigation. 35(6). 388–398. 47 indexed citations
20.
Vesely, Brian A., et al.. (2005). Four peptide hormones decrease the number of human breast adenocarcinoma cells. European Journal of Clinical Investigation. 35(1). 60–69. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen Raventós-Suárez Breakdown of academic impact, for papers by Girish Rachakonda Breakdown of academic impact, for papers by Shusaku Mizukami Breakdown of academic impact, for papers by M Ghione Breakdown of academic impact, for papers by Sameena Khan Breakdown of academic impact, for papers by K. Vosbeck Breakdown of academic impact, for papers by Annette L. Bodley Breakdown of academic impact, for papers by Hairong Xiong Breakdown of academic impact, for papers by Pia Rauch Breakdown of academic impact, for papers by Olga A. Smirnova
Rankless by CCL
2026